Alteryx Inc - Ordinary Shares (AYX) 10-Q 27 Apr 23 2023 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2023	Apr. 20, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-38034
Entity Registrant Name	Alteryx, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	90-0673106
Entity Address, Address Line One	17200 Laguna Canyon Road,
Entity Address, City or Town	Irvine,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92618
City Area Code	888
Local Phone Number	836-4274
Title of 12(b) Security	Class A Common Stock, $0.0001 par value per share
Trading Symbol	AYX
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001689923
Current Fiscal Year End Date	--12-31
Class A common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		62,563,225
Class B common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		7,886,450

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue:
Total revenue	$ 199,087	$ 157,941
Cost of revenue:
Total cost of revenue	30,525	24,241
Gross profit	168,562	133,700
Operating expenses:
Research and development	58,741	50,150
Sales and marketing	150,817	115,610
General and administrative	47,195	59,440
Impairment of long-lived assets	0	8,239
Total operating expenses	256,753	233,439
Loss from operations	(88,191)	(99,739)
Interest expense	(5,229)	(2,390)
Other income (expense), net	6,960	(1,950)
Loss before provision for income taxes	(86,460)	(104,079)
Provision for income taxes	2,575	1,488
Net loss	$ (89,035)	$ (105,567)
Net income (loss) per share attributable to common stockholders, basic (in dollars per share)	$ (1.27)	$ (1.56)
Net income (loss) per share attributable to common stockholders, diluted (in dollars per share)	$ (1.27)	$ (1.56)
Weighted-average shares used to compute net income (loss) per share attributable to common stockholders, basic (in shares)	69,874	67,826
Weighted-average shares used to compute net income (loss) per share attributable to common stockholders, diluted (in shares)	69,874	67,826
Other comprehensive income (loss), net of tax:
Net unrealized holding gain (loss) on investments, net of tax	$ 1,856	$ (2,151)
Foreign currency translation adjustments, net of tax	(3,808)	2,180
Other comprehensive income (loss), net of tax	(1,952)	29
Total comprehensive loss	(90,987)	(105,538)
Subscription-based software license
Revenue:
Total revenue	91,528	63,089
Cost of revenue:
Total cost of revenue	1,955	2,102
PCS and services
Revenue:
Total revenue	107,559	94,852
Cost of revenue:
Total cost of revenue	$ 28,570	$ 22,139

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 593,491	$ 104,751
Short-term investments	207,534	237,040
Accounts receivable, net	94,773	259,590
Prepaid expenses and other current assets	159,949	145,767
Total current assets	1,055,747	747,148
Property and equipment, net	69,821	69,157
Operating lease right-of-use assets	49,878	50,997
Long-term investments	84,043	90,184
Goodwill	397,825	398,091
Intangible assets, net	57,171	60,901
Total	134,911	140,806
Total assets	1,849,396	1,557,284
Current liabilities:
Accounts payable	11,303	13,883
Accrued payroll and payroll related liabilities	57,675	81,206
Accrued expenses and other current liabilities	50,695	56,592
Deferred revenue	212,458	276,160
Convertible senior notes, net	82,679	84,571
Total current liabilities	414,810	512,412
Long-term debt, net	1,234,252	792,921
Operating lease liabilities	58,318	61,265
Other Liabilities, Noncurrent	16,834	17,030
Total liabilities	1,724,214	1,383,628
Commitments and contingencies (Note 10)
Stockholders’ equity:
Preferred stock, $0.0001 par value: 10,000 shares authorized as of March 31, 2023 and December 31, 2022, respectively; no shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively	0	0
Common stock, $0.0001 par value: 500,000 Class A shares authorized, 62,541 and 61,616 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively; 500,000 Class B shares authorized, 7,886 and 7,886 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively	8	7
Additional paid-in capital	664,946	622,434
Accumulated deficit	(532,194)	(443,159)
Accumulated other comprehensive loss	(7,578)	(5,626)
Total stockholders’ equity	125,182	173,656
Total liabilities and stockholders’ equity	$ 1,849,396	$ 1,557,284

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Class A common stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	62,541,000	61,616,000
Common stock, shares outstanding (in shares)	62,541,000	61,616,000
Class B common stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	7,886,000	7,886,000
Common stock, shares outstanding (in shares)	7,886,000	7,886,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021			67,534
Beginning balance at Dec. 31, 2021	$ 402,754	$ (111,195)	$ 7	$ 598,710	$ (176,964)	$ (190,429)	$ 65,769	$ (5,534)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued pursuant to restricted stock awards, net of tax withholdings related to vesting of restricted stock units (in shares)			434
Shares issued pursuant to restricted stock unit awards, net of tax withholdings related to vesting of restricted stock units	(14,126)			(14,126)
Exercise of stock options and issuance of shares in connection with employee stock purchase plan (in shares)			160
Exercise of stock options and issuance of shares in connection with employee stock purchase plan	4,741			4,741
Stock-based compensation	53,957			53,957
Cumulative translation adjustment	2,180							2,180
Unrealized gain (loss) on investments, net of tax	(2,151)							(2,151)
Net loss	(105,567)					(105,567)
Ending balance (in shares) at Mar. 31, 2022			68,128
Ending balance at Mar. 31, 2022	230,593		$ 7	466,318		(230,227)		(5,505)
Beginning balance (in shares) at Dec. 31, 2022			69,502
Beginning balance at Dec. 31, 2022	173,656		$ 7	622,434		(443,159)		(5,626)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued pursuant to restricted stock awards, net of tax withholdings related to vesting of restricted stock units (in shares)			767
Shares issued pursuant to restricted stock unit awards, net of tax withholdings related to vesting of restricted stock units	(27,164)			(27,164)
Exercise of stock options and issuance of shares in connection with employee stock purchase plan (in shares)			159
Exercise of stock options and issuance of shares in connection with employee stock purchase plan	8,730		$ 1	8,729
Stock-based compensation	60,950			60,950
Settlement of capped calls (in shares)			(10)
Conversion on 2023 Notes, net of tax (in shares)			9
Conversion of 2023 Notes, net of tax	(3)			(3)
Cumulative translation adjustment	(3,808)							(3,808)
Unrealized gain (loss) on investments, net of tax	1,856							1,856
Net loss	(89,035)					(89,035)
Ending balance (in shares) at Mar. 31, 2023			70,427
Ending balance at Mar. 31, 2023	$ 125,182		$ 8	$ 664,946		$ (532,194)		$ (7,578)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (89,035)	$ (105,567)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	8,975	7,389
Non-cash operating lease cost	3,141	5,152
Stock-based compensation	57,473	45,162
Amortization (accretion) of discounts and premiums on investments, net	(941)	477
Amortization of debt discount and issuance costs	892	780
Deferred income taxes	1,218	360
Impairment of long-lived assets	0	8,239
Other non-cash operating activities, net	(2,892)	4,649
Changes in operating assets and liabilities, net of effect of business acquisitions:
Accounts receivable	166,098	120,727
Deferred commissions	1,014	1,281
Prepaid expenses, other current assets, and other assets	(3,817)	(9,516)
Accounts payable	(2,818)	1,854
Accrued payroll and payroll related liabilities	(22,950)	(26,391)
Accrued expenses, other current liabilities, operating lease liabilities, and other liabilities	(13,303)	(7,860)
Deferred revenue	(63,099)	(37,918)
Net cash provided by operating activities	39,956	8,818
Cash flows from investing activities:
Capitalized software development costs	(6,214)	(2,672)
Purchases of property and equipment	(1,136)	(6,629)
Cash paid in acquisitions, net of cash acquired	0	(389,769)
Purchases of investments	(52,681)	(38,106)
Sales and maturities of investments	84,720	433,190
Net cash provided by (used in) investing activities	24,689	(3,986)
Cash flows from financing activities:
Proceeds from issuance of senior notes, net of issuance costs	441,749	0
Principal payments on 2023 convertible senior notes	(2,000)	0
Proceeds from exercise of stock options and issuance of shares from employee stock purchase plan	8,730	4,741
Minimum tax withholding paid on behalf of employees for restricted stock units	(27,164)	(14,126)
Net cash provided by (used in) financing activities	421,315	(9,385)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	399	(684)
Net increase (decrease) in cash, cash equivalents and restricted cash	486,359	(5,237)
Cash, cash equivalents and restricted cash—beginning of period	109,451	154,623
Cash, cash equivalents and restricted cash—end of period	595,810	149,386
Supplemental disclosure of cash flow information:
Cash paid for interest	3,000	3,000
Cash paid for income taxes	1,003	1,110
Cash paid for amounts included in the measurement of operating lease liabilities	6,075	7,027
Supplemental disclosure of noncash investing and financing activities:
Property and equipment recorded in accounts payable and accrued expenses and other current liabilities	876	6,277
Right-of-use assets obtained in exchange for new operating lease liabilities	0	2,727
Stock-based compensation included in capitalized software development costs	1,535	611
Commissions paid with Class A common stock	2,709	8,455
Debt issuance costs recorded in accrued expenses and other current liabilities	$ 1,207	$ 0

Business

Business	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business	Business Our Company Alteryx, Inc. and its subsidiaries, or we, our, or us, are headquartered in Irvine, California. The Alteryx Analytics Automation Platform empowers “analytics for all” by delivering easy, end-to-end automation of data engineering, analytics, reporting, machine learning, and data science processes, enabling enterprises to democratize data analytics across their organizations for a broad range of use cases. Whether working in the cloud or on-premise, data workers, regardless of technical acumen, are empowered to be curious and solve problems. With the Alteryx Analytics Automation Platform, users can automate the full range of analytics and data science processes, embed intelligent decision-making and actions, and empower their organization to enable top and bottom-line impact, efficiency gains, and rapid upskilling. Basis of Presentation The accompanying unaudited condensed consolidated financial statements, which include the accounts of Alteryx, Inc. and its subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP, for interim periods. Certain information and disclosures normally included in consolidated financial statements presented in accordance with U.S. GAAP have been condensed or omitted. Certain reclassifications have been made to the fiscal year 2022 condensed consolidated financial statements to conform to the fiscal year 2023 presentation. The reclassifications had no impact on comprehensive loss, total assets, total liabilities, or stockholders’ equity. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes included in our Annual Report on Form 10-K for the year ended December 31, 2022, or the Annual Report, filed with the Securities and Exchange Commission, or SEC, on February 10, 2023. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments that are necessary to state fairly the financial position, results of operations, comprehensive loss, and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending December 31, 2023.

Significant Accounting Policies

Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Other than as described below, there have been no changes to our accounting policies disclosed in our audited consolidated financial statements and the related notes for the year ended December 31, 2022. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates and assumptions. On an ongoing basis, our management evaluates these estimates and assumptions, including those related to determination of standalone selling prices of our products and services, income tax valuations, stock-based compensation, and goodwill and intangible assets valuations and recoverability. We base our estimates on historical data and experience, as well as various other factors that our management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities. Recent Accounting Pronouncements There have been no recent accounting pronouncements, changes in accounting pronouncements, or recently adopted accounting guidance during the three months ended March 31, 2023 that are of significance or potential significance to us.

Revenue

Revenue	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Revenue related to our subscription-based software licenses is recognized at a point in time when the platform is first made available to the customer, or the beginning of the subscription term, if later. Revenue related to post-contract support, or PCS, subscription-based professional services, cloud-based offerings, and subscriptions to third-party syndicated data is recognized ratably over the subscription term, with the exception of professional services related to training and enablement services. Revenue related to professional services that are training and enablement services is recognized at a point in time as the services are performed. For the periods presented, revenue from professional services was not material. Disaggregation of Revenue The disaggregation of revenue by region was as follows (in thousands): Three Months Ended March 31, 2023 2022 Revenue by region: United States $ 143,665 $ 110,033 International 55,422 47,908 Total $ 199,087 $ 157,941 No country outside the United States comprised more than 10% of revenue for any of the periods presented. Our operations outside the United States include sales offices in Australia, France, Germany, Japan, Singapore, United Arab Emirates, and the United Kingdom, and research and development centers in Australia, the Czech Republic, India, and Ukraine. Revenue by location is determined by the billing address of the customer. Contract Assets and Contract Liabilities Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. Contract assets primarily relate to unbilled amounts for contracts with customers for which the amount of revenue recognized exceeds the amount billed to the customer. Contract assets are transferred to accounts receivable when the right to invoice becomes unconditional. Contract liabilities, or deferred revenue, are recorded for amounts that are collected in advance of the satisfaction of performance obligations. As of March 31, 2023 and December 31, 2022, we had deferred revenue of $212.5 million and $276.2 million, respectively, included in current deferred revenue and $6.2 million and $4.0 million, respectively, included in other liabilities on our condensed consolidated balance sheet. During the three months ended March 31, 2023 and 2022, we recognized $127.0 million and $83.2 million, respectively, of revenue related to amounts that were included in deferred revenue as of December 31, 2022 and 2021, respectively. Assets Recognized from the Costs to Obtain our Contracts with Customers We recognize an asset for the incremental costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. This primarily consists of sales commissions and partner referral fees that are earned upon execution of the related contracts. We amortize these deferred commissions, which include partner referral fees, proportionate with related revenues over the benefit period. A summary of the activity impacting our deferred commissions during the three months ended March 31, 2023 and 2022 is presented below (in thousands): Three Months Ended March 31, 2023 2022 Beginning balance (1) $ 96,239 $ 69,817 Additional deferred commissions 17,065 10,968 Amortization of deferred commissions (17,965) (13,028) Effects of foreign currency translation 278 (286) Ending balance $ 95,617 $ 67,471 (1) Of the total amount of commissions deferred as of January 1, 2023 and January 1, 2022, $1.6 million and $6.3 million were paid in shares of our Class A common stock in the three months ended March 31, 2023 and March 31, 2022, respectively. As of March 31, 2023 and 2022, $42.2 million and $30.8 million, respectively, of our deferred commissions were expected to be amortized within the next 12 months and therefore were included in prepaid expenses and other current assets. The remaining amount of our deferred commissions is included in other assets. There were no impairments of assets related to deferred commissions during each of the three months ended March 31, 2023 and 2022. There were no assets recognized related to the costs to fulfill contracts during each of the three months ended March 31, 2023 and 2022 as these costs were not material. Remaining Performance Obligations Transaction price allocated to the remaining performance obligations represents contracted revenue that has not yet been recognized, which includes deferred revenue on our condensed consolidated balance sheets and unbilled amounts that will be recognized as revenue in future periods. As of March 31, 2023, we had an aggregate transaction price of $508.8 million allocated to unsatisfied performance obligations related primarily to PCS, cloud-based offerings, and subscriptions to third-party syndicated data. We expect to recognize $474.2 million as revenue over the next 24 months, with the remaining amount expected to be recognized thereafter.

Business Combinations

Business Combinations	3 Months Ended
	Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations Trifacta Inc. On February 7, 2022, we acquired 100% of the outstanding equity of Trifacta Inc., or Trifacta, pursuant to an Agreement and Plan of Merger, dated January 6, 2022, or the Trifacta Merger Agreement. The acquisition was made to augment our product and go-to-market teams and acquire developed technology to advance our cloud-based functionalities. The aggregate consideration payable in exchange for all of the outstanding equity interests in Trifacta, inclusive of customary adjustments set forth in the Trifacta Merger Agreement, was $398.4 million. The transaction costs associated with the acquisition were approximately $11.3 million, of which $7.8 million was incurred during the three months ended March 31, 2022 and was recorded in general and administrative expense. The purchase consideration for the acquisition primarily consisted of $341.4 million of goodwill and $48.5 million in completed technology. We determined the fair value of the developed technology acquired using the multi-period excess earnings model, which is a variation of the income approach that estimates the value of the assets based on the present value of the incremental after-tax cash flow attributable only to the intangible assets. This model utilizes certain unobservable inputs classified as Level 3 measurements as defined by ASC 820, Fair Value Measurements and Disclosures , or ASC 820. Key inputs utilized in the models include a discount rate of 16.5% and estimated revenue and expense forecasts. The operations of Trifacta are included in our operating results from the date of acquisition. We have not separately disclosed the amount of revenue or earnings related to the Trifacta acquisition as the operations of Trifacta were integrated into the operations of our company from the date of acquisition, and thus it would be immaterial and impractical to do so. In addition, the unaudited pro forma results of operations assuming the Trifacta acquisition had taken place at the beginning of each period are not provided as the historical operating results of Trifacta were not material.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Instruments Measured at Fair Value on a Recurring Basis. The following tables present our cash and cash equivalents’ and investments’ costs, net unrealized gains (losses), and fair value by major security type recorded as cash and cash equivalents or short-term or long-term investments as of March 31, 2023 and December 31, 2022 (in thousands): As of March 31, 2023 Cost Net Fair Value Cash and Short-term Long-term Cash $ 72,343 $ — $ 72,343 $ 72,343 $ — $ — Level 1: Money market funds 488,317 — 488,317 488,317 — — Subtotal 488,317 — 488,317 488,317 — — Level 2: Commercial paper 76,489 (36) 76,453 29,843 46,610 — Certificates of deposit 5,016 — 5,016 — 5,016 — U.S. Treasury and agency bonds 205,558 (1,566) 203,992 2,988 121,718 79,286 Corporate bonds 39,281 (334) 38,947 — 34,190 4,757 Subtotal 326,344 (1,936) 324,408 32,831 207,534 84,043 Level 3: — — — — — — Total $ 887,004 $ (1,936) $ 885,068 $ 593,491 $ 207,534 $ 84,043 As of December 31, 2022 Cost Net Fair Value Cash and Short-term Long-term Cash $ 62,880 $ — $ 62,880 $ 62,880 $ — $ — Level 1: Money market funds 20,210 — 20,210 20,210 — — Subtotal 20,210 — 20,210 20,210 — — Level 2: Commercial paper 60,197 (115) 60,082 21,064 39,018 — Certificates of deposit 6,000 (3) 5,997 — 5,997 — U.S. Treasury and agency bonds 236,559 (3,065) 233,494 597 156,090 76,807 Corporate bonds 46,171 (609) 45,562 — 35,935 9,627 Subtotal 348,927 (3,792) 345,135 21,661 237,040 86,434 Level 3: — — — — — — Total $ 432,017 $ (3,792) $ 428,225 $ 104,751 $ 237,040 $ 86,434 All long-term investments had maturities between one As of March 31, 2023, we had gross unrealized losses of $2.1 million with respect to $238.4 million aggregate fair value of our available-for-sale securities, and we do not intend to sell, nor is it more likely than not that we will be required to sell, these investments before recovery of their amortized cost basis. These gross unrealized losses were classified in accumulated other comprehensive loss in our condensed consolidated balance sheets as of March 31, 2023. Instruments Not Recorded at Fair Value on a Recurring Basis. We estimate the fair value of our Notes, as defined in Note 8. Debt , carried at face value, less unamortized discount and issuance costs, quarterly for disclosure purposes. The estimated fair value of our Notes is determined by Level 2 inputs and is based on observable market data including prices for similar instruments. As of March 31, 2023 and December 31, 2022, the fair value of our Notes was $1,281.3 million and $805.8 million, respectively. The carrying amounts of our accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued liabilities approximate their current fair value because of their nature and relatively short maturity dates or durations. Assets and Liabilities Recorded at Fair Value on a Non-Recurring Basis. See Note 4, Business Combinations , and Note 7, Goodwill and Intangible Assets , of these notes to our condensed consolidated financial statements for fair value measurements of certain assets and liabilities recorded at fair value on a non-recurring basis. These include the fair value of assets acquired and liabilities assumed in a business acquisition, and goodwill and other long-lived assets when they are held for sale or determin ed to be impaired. Other Investments. The table above does not include our debt and equity investments in which we do not have a controlling interest or significant influence. As of March 31, 2023, the balance of our investments was $6.4 million, which is included in other assets, compared to $3.8 million as of December 31, 2022, which is included in long-term investments. Since our initial investments, there have been no impairments or adjustments to the carrying amounts of our equity or debt investments.

Balance Sheet Components

Balance Sheet Components	3 Months Ended
	Mar. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Balance Sheet Components	Balance Sheet Components Prepaid expenses and other current assets consisted of the following (in thousands): March 31, 2023 December 31, 2022 Contract asset $ 68,518 $ 59,669 Deferred commissions 42,240 41,139 Prepaid expenses 36,520 37,783 Other 12,671 7,176 Total $ 159,949 $ 145,767 Other assets consisted of the following (in thousands): March 31, 2023 December 31, 2022 Contract asset $ 63,931 $ 71,448 Deferred commissions 53,378 55,100 Other 17,602 14,258 Total $ 134,911 $ 140,806

Goodwill and Intangible Assets

Goodwill and Intangible Assets	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The change in carrying amount of goodwill for the three months ended March 31, 2023 was as follows (in thousands): Goodwill as of December 31, 2022 $ 398,091 Effects of foreign currency translation (266) Goodwill as of March 31, 2023 $ 397,825 Intangible assets consisted of the following (in thousands, except years): As of March 31, 2023 Remaining Weighted-Average Useful Life in Years Gross Carrying Accumulated Net Carrying Customer relationships 1.9 $ 2,436 $ (1,431) $ 1,005 Completed technology 5.5 82,023 (26,785) 55,238 Trade names 1.9 1,500 (572) 928 $ 85,959 $ (28,788) $ 57,171 As of December 31, 2022 Remaining Weighted-Average Useful Life in Years Gross Carrying Accumulated Net Carrying Customer relationships 2.1 $ 2,466 $ (1,320) $ 1,146 Completed technology 5.6 82,209 (23,506) 58,703 Trade names 2.1 1,500 (448) 1,052 $ 86,175 $ (25,274) $ 60,901 The following table presents our estimates of remaining amortization expense for finite-lived intangible assets at March 31, 2023 (in thousands): Remainder of 2023 $ 8,872 2024 11,779 2025 10,181 2026 9,298 2027 8,311 Thereafter 8,730 Total amortization expense $ 57,171

Debt

Debt	3 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
Debt	Debt Our debt consisted of the following, which comprises the current portion of certain convertible notes, our long-term convertible notes, and our long-term senior unsecured notes, each as further described below (in thousands): As of March 31, 2023 As of December 31, 2022 2023 Notes 2024 Notes 2026 Notes 2028 Notes 2023 Notes 2024 Notes 2026 Notes Liability: Principal $ 82,748 $ 400,000 $ 400,000 $ 450,000 $ 84,748 $ 400,000 $ 400,000 Less: debt discount and issuance costs, net of amortization (69) (2,292) (4,102) (9,354) (177) (2,700) (4,379) Net carrying amount $ 82,679 $ 397,708 $ 395,898 $ 440,646 $ 84,571 $ 397,300 $ 395,621 Senior Unsecured Notes In March 2023, we sold $450.0 million aggregate principal amount of our 8.75% senior notes due 2028, or the 2028 Notes, in a private offering to qualified institutional buyers pursuant to Rule 144A promulgated under the Securities Act of 1933, as amended, or the Securities Act, and outside the United States pursuant to Regulation S under the Securities Act. The 2028 Notes have not been registered, and we do not intend to register the 2028 Notes, under the Securities Act or the securities laws of any other jurisdiction. The 2028 Notes are fully and unconditionally guaranteed on a senior unsecured basis by certain of our subsidiaries. Interest on the 2028 Notes is payable semi-annually in arrears on March 15 and September 15 of each year, beginning September 15, 2023. Unless earlier redeemed or repurchased, the 2028 Notes will mature on March 15, 2028. The effective interest rate of the 2028 Notes is 9.27%. The Indenture governing the 2028 Notes gives us the option to redeem some or all of the 2028 Notes at the redemption prices set forth in the Indenture, together with accrued and unpaid interest, if any, to, but excluding, the date of redemption. We may make optional redemptions at prices equal to 100% of the principal amount, plus accrued and unpaid interest, if any, to the redemption date, plus applicable “make-whole” premiums. In addition, we may redeem up to 40% of the original aggregate principal amount of the 2028 Notes using the net cash proceeds of certain equity offerings completed on or before March 15, 2025 at a redemption price of 108.75%. The 2028 Notes rank equal in right of payment to all of our and the guarantors’ existing and future senior indebtedness, including our 2023 Notes, 2024 Notes, and 2026 Notes, each as defined below, and do not contain financial covenants but include covenants that, among other things, limit our ability to grant liens on certain assets to secure debt, grant a subsidiary guarantee of certain debt without also providing a guarantee of the 2028 Notes, and consolidate or merge with or into, or sell or otherwise dispose of all or substantially all of our assets to, another person. Convertible Senior Notes The following table presents details of our convertible senior notes, which are further discussed below (original principal in thousands): Month Issued Maturity Date Original Principal (including over-allotment) Coupon Interest Rate Effective Interest Rate Conversion Rate Initial Conversion Price 2023 Notes May and June 2018 June 1, 2023 $ 230,000 0.5 % 1.00 % $ 22.5572 $ 44.33 2024 Notes August 2019 August 1, 2024 $ 400,000 0.5 % 0.93 % $ 5.2809 $ 189.36 2026 Notes August 2019 August 1, 2026 $ 400,000 1.0 % 1.32 % $ 5.2809 $ 189.36 As further defined and described below, the 2024 Notes and the 2026 Notes are together referred to as the 2024 & 2026 Notes, the 2023 Notes and the 2024 & 2026 Notes are collectively referred to as the Convertible Notes, and the 2023 Notes, 2024 & 2026 Notes, and 2028 Notes are collectively referred to as the Notes. The 2023 Notes are our senior, unsecured obligations and interest is payable semi-annually in arrears on June 1 and December 1 of each year beginning December 1, 2018. The 2024 & 2026 Notes are our senior, unsecured obligations and interest is payable semi-annually in arrears on February 1 and August 1 of each year beginning February 1, 2020. Prior to the close of business on the business day immediately preceding March 1, 2023, or the 2023 Conversion Date, in the case of the 2023 Notes, or May 1, 2024, or the 2024 Conversion Date, in the case of the 2024 Notes, or May 1, 2026, or the 2026 Conversion Date, in the case of the 2026 Notes, the respective Convertible Notes are convertible at the option of holders only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the relevant maturity date. The applicable conversion rate is subject to customary adjustments for certain events as described in the applicable indenture between us and U.S. Bank National Association, as trustee, or, collectively, the Indentures. Upon conversion, the Convertible Notes may be settled in shares of our Class A common stock, cash, or a combination of cash and shares of our Class A common stock, at our election. Prior to the close of business on the business day immediately preceding the applicable Conversion Date, the applicable series of Convertible Notes is convertible at the option of the holders under the following circumstances: • during any calendar quarter commencing after the calendar quarter subsequent to the calendar quarter in which the applicable series of Convertible Notes was issued (and only during such calendar quarter), if the last reported sale price of our Class A common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the applicable series of Convertible Notes on each applicable trading day; • during the five-business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the applicable series of Convertible Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of our Class A common stock and the applicable conversion rate of the applicable series of Convertible Notes on such applicable trading day; or • upon the occurrence of specified corporate events described in the applicable Indenture. Beginning on the 2023 Conversion Date, holders may convert all or any portion of their 2023 Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. As the 2023 Notes mature on June 1, 2023 and are convertible at the holder’s option until the maturity date, they were classified as current liabilities on the condensed consolidated balance sheet as of March 31, 2023. We will utilize a combination settlement method and settle the remaining principal amount of the 2023 Notes with cash and conversion premium in shares. As of March 31, 2023, the aggregate if-converted value of the 2023 Notes exceeded their aggregate principal amount by $27.1 million. As of March 31, 2023, the 2024 & 2026 Notes were not convertible. We may not redeem any series of Convertible Notes prior to the relevant maturity date. Holders of any series of Convertible Notes have the right to require us to repurchase for cash all or a portion of their applicable series of Convertible Notes, at 100% of its respective principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change as defined in the applicable Indenture for such series of Convertible Notes. We are also required to increase the conversion rate for holders who convert their Convertible Notes in connection with certain corporate events occurring prior to the relevant maturity date. The Convertible Notes are our senior unsecured obligations and rank (i) senior in right of payment to any of our indebtedness and other liabilities that are expressly subordinated in right of payment to the Convertible Notes, (ii) equal in right of payment among all series of Convertible Notes, to the 2028 Notes, and to any other existing and future indebtedness and other liabilities that are not subordinated, (iii) effectively junior in right of payment to any of our secured indebtedness and other liabilities to the extent of the value of the assets securing such indebtedness and other liabilities, and (iv) structurally subordinated to all existing and future indebtedness (including the guarantees of the 2028 Notes by certain of our subsidiaries) and other liabilities (including trade payables) of our current or future subsidiaries. Capped Call Transactions In connection with the pricing of the 2023 Notes, we entered into privately negotiated capped call transactions with an affiliate of one of the initial purchasers of the 2023 Notes and other financial institutions. In connection with the pricing of the 2024 & 2026 Notes, we entered into privately negotiated capped call transactions with other financial institutions. The capped call transactions are expected generally to reduce or offset potential dilution to holders of our common stock and/or offset the potential cash payments that we could be required to make in excess of the principal amount upon any conversion of the applicable series of Convertible Notes under certain circumstances, with such reduction and/or offset subject to a cap based on the cap price. Under the capped call transactions, we purchased capped call options that in the aggregate relate to the total number of shares of our Class A common stock underlying the applicable series of Convertible Notes, with an initial strike price of approximately $44.33 per share in the case of the 2023 Notes, which corresponds to the initial conversion price of the 2023 Notes, and approximately $189.36 per share in the case of the 2024 & 2026 Notes, which corresponds to the initial conversion price of each of the 2024 & 2026 Notes. Further, the capped call options are subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the applicable series of Convertible Notes, and have a cap price of $62.22 per share in the case of the 2023 Notes, and $315.60 per share in the case of the 2024 & 2026 Notes. In connection with the conversion of a portion of the 2023 Notes discussed below, we terminated a corresponding portion of the existing capped call transactions that we entered into in connection with the issuance of the 2023 Notes, which resulted in the net share settlement and our receipt and retirement of 9,394 shares of Class A common stock. Conversion of 2023 Notes During the three months ended March 31, 2023, we settled a request to convert $2.0 million aggregate principal amount of the 2023 Notes for $2.0 million in cash and 8,598 shares of Class A common stock. The following table sets forth interest expense recognized related to the Notes (in thousands): Three Months Ended March 31, 2023 2022 Contractual interest expense $ 4,337 $ 1,606 Amortization of debt issuance costs and discount 892 780 Total $ 5,229 $ 2,386 Contractual Obligations of Notes The following table sets forth future contractual obligations of contractual interest and principal related to the Notes (in thousands): Payments Due by Period Remainder of 2023 $ 106,627 2024 445,375 2025 43,375 2026 443,375 2027 39,375 2028 469,688 Total principal and related contractual interest $ 1,547,815

Equity Awards

Equity Awards	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Equity Awards	Equity Awards Stock Options Stock option activity, excluding activity related to the employee stock purchase plan, during the three months ended March 31, 2023 consisted of the following (in thousands, except weighted-average information): Options Weighted- Options outstanding at December 31, 2022 1,106 $ 41.43 Granted — — Exercised (11) 13.07 Canceled/forfeited — — Options outstanding at March 31, 2023 1,095 $ 41.71 There were no options granted during the three months ended March 31, 2023. As of March 31, 2023, there was $2.4 million of unrecognized compensation cost related to unvested stock options, which is expected to be recognized over a weighted-average period of 1.1 years. Restricted Stock Units Restricted stock unit, or RSU, and performance-based RSU, or PRSU, activity during the three months ended March 31, 2023 consisted of the following (in thousands, except weighted-average information): Awards Outstanding (1) Weighted- Average Grant Date Fair Value (1) RSUs outstanding at December 31, 2022 9,928 $ 55.70 Granted 2,710 64.60 Vested (1,186) 68.03 Canceled/forfeited (419) 64.09 RSUs outstanding at March 31, 2023 11,033 $ 56.24 (1) Includes restricted stock units with market, performance, and/or service conditions. During the three months ended March 31, 2023, we granted PRSUs to certain executives with a grant date fair value of $13.9 million. These PRSUs are subject to vesting based on performance and service conditions and, assuming such conditions are met, will vest quarterly beginning in 2024 based upon the percentage achievement of certain annualized recurring revenue and operating margin metrics or will otherwise be forfeited on December 31, 2023 if the targets are not met. As of March 31, 2023, total unrecognized compensation expense related to unvested RSUs and PRSUs was approximately $518.8 million, which is expected to be recognized over a weighted-average period of 2.2 years. We classified stock-based compensation expense in the accompanying condensed consolidated statements of operations and comprehensive loss as follows (in thousands): Three Months Ended March 31, 2023 2022 Cost of revenue $ 3,315 $ 3,404 Research and development 14,056 11,174 Sales and marketing 22,623 15,220 General and administrative 17,479 15,364 Total $ 57,473 $ 45,162

Contingencies

Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies Indemnification In the ordinary course of business, we enter into agreements in which we may agree to indemnify other parties with respect to certain matters, including losses resulting from claims of intellectual property infringement, damages to property or persons, business losses, or other liabilities. In addition, we have entered into indemnification agreements with our directors, executive officers, and certain other employees that will require us to indemnify them against liabilities that may arise by reason of their status or service as directors, officers, or employees. The terms of these indemnification agreements with our directors, executive officers, and other employees are generally perpetual after execution of the agreement. The maximum potential amount of future payments we could be required to make under certain of these indemnification provisions is unlimited; however, we maintain insurance that reduces our exposure and enables us to recover a portion of any future amounts paid. As of March 31, 2023 and December 31, 2022, we have not accrued a liability for indemnification provisions we agree to in the ordinary course of business or with our directors, executive officers, and certain other employees pursuant to indemnification agreements because the likelihood of incurring a payment obligation, if any, in connection with these arrangements is not probable or reasonably estimable. Litigation From time to time, we may be involved in lawsuits, claims, investigations, and proceedings, consisting of intellectual property, commercial, employment, and other matters, which arise in the ordinary course of business. We are not currently party to any material legal proceedings or claims, nor are we aware of any pending or threatened legal proceedings or claims that could have a material adverse effect on our business, operating results, cash flows, or financial condition should such legal proceedings or claims be resolved unfavorably.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The following table presents details of the provision for income taxes and our effective tax rates (in thousands, except percentages): Three Months Ended March 31, 2023 2022 Provision for income taxes $ 2,575 $ 1,488 Effective tax rate (3.0) % (1.4) % We account for income taxes according to ASC 740, which, among other things, requires that we estimate our annual effective income tax rate for the full year and apply it to pre-tax income (loss) for each interim period, taking into account year-to-date amounts and projected results for the full year. We periodically evaluate whether we will recover a portion or all of our deferred tax assets. We record a valuation allowance against our deferred tax assets if and to the extent it is more likely than not that we will not recover our deferred tax assets. In evaluating the need for a valuation allowance, we weight all relevant positive and negative evidence, including among other factors, historical financial performance, forecasts of income over the applicable carryforward periods, and our market environment, with each piece weighted based on its reliability. As of March 31, 2023, we had insufficient objective positive evidence that we will generate sufficient future pre-tax income to overcome the negative evidence of cumulative losses. Accordingly, we continue to record a full valuation allowance against our net U.S. and U.K. deferred tax assets as of March 31, 2023. We account for the tax effects of discrete events in the interim period they occur. The provision for income taxes consists of federal, foreign, state, and local income taxes. Our effective tax rate differs from the statutory U.S. income tax rate due to the effect of state and local income taxes, differing tax rates imposed on income earned in foreign jurisdictions and in the United States, losses in foreign jurisdictions, certain nondeductible expenses, excess tax deductions, and the changes in valuation allowances against our deferred tax assets. Our effective tax rate could change significantly from quarter to quarter because of recurring and nonrecurring factors. The provision for income taxes for each of the three months ended March 31, 2022 and 2023 was primarily attributable to increased foreign withholding tax and state minimum tax in the related jurisdictions. In addition, there was an increase in foreign income taxes due to profitability in certain foreign subsidiaries. We did not recognize benefits from excess tax deductions from exercised stock options and settled RSUs or net operating losses for either the three months ended March 31, 2022 or 2023 as a result of the full valuation allowance against our U.S. and U.K. net deferred tax assets. Neither we nor any of our subsidiaries are currently under examination from tax authorities in the jurisdictions in which we do business.

Basic and Diluted Net Loss Per

Basic and Diluted Net Loss Per Share	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Basic and Diluted Net Loss Per Share	Basic and Diluted Net Loss Per Share The following table presents the computation of net loss per share (in thousands, except per share amounts): Three Months Ended March 31, 2023 2022 Numerator: Net loss attributable to common stockholders $ (89,035) $ (105,567) Denominator: Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted 69,874 67,826 Net loss per share attributable to common stockholders, basic and diluted $ (1.27) $ (1.56) Since we were in a loss position for all periods presented, basic net loss is the same as diluted net loss per share for all periods as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. The following weighted-average equivalent shares of common stock were excluded from the diluted net loss per share calculation because their inclusion would have been anti-dilutive (in thousands): Three Months Ended March 31, 2023 2022 Stock awards 8,284 7,018 Convertible senior notes 5,618 6,136 Total shares excluded from net loss per share 13,902 13,154

Subsequent Event

Subsequent Event	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Event	Subsequent EventsOn April 27, 2023, we announced a workforce reduction plan, or the Workforce Reduction Plan, intended to reduce operating costs, improve operating margins, and continue advancing our ongoing commitment to profitable growth. The Workforce Reduction Plan is expected to impact primarily employees in our sales and marketing and general and administrative organizations. We currently estimate that we will incur charges of approximately $11.0 million to $13.0 million in connection with the Workforce Reduction Plan, consisting of cash expenditures for the notice period and severance payments, employee benefits, and job placement services. We expect that the majority of the charges will be incurred in the second quarter of 2023 and that the execution of the Workforce Reduction Plan will be substantially complete by the end of the third quarter of 2023.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements, which include the accounts of Alteryx, Inc. and its subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP, for interim periods. Certain information and disclosures normally included in consolidated financial statements presented in accordance with U.S. GAAP have been condensed or omitted. Certain reclassifications have been made to the fiscal year 2022 condensed consolidated financial statements to conform to the fiscal year 2023 presentation. The reclassifications had no impact on comprehensive loss, total assets, total liabilities, or stockholders’ equity. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes included in our Annual Report on Form 10-K for the year ended December 31, 2022, or the Annual Report, filed with the Securities and Exchange Commission, or SEC, on February 10, 2023. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments that are necessary to state fairly the financial position, results of operations, comprehensive loss, and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending December 31, 2023.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates and assumptions. On an ongoing basis, our management evaluates these estimates and assumptions, including those related to determination of standalone selling prices of our products and services, income tax valuations, stock-based compensation, and goodwill and intangible assets valuations and recoverability. We base our estimates on historical data and experience, as well as various other factors that our management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities.
Recent Accounting Pronouncements	Recent Accounting Pronouncements There have been no recent accounting pronouncements, changes in accounting pronouncements, or recently adopted accounting guidance during the three months ended March 31, 2023 that are of significance or potential significance to us.
Income Taxes	We account for income taxes according to ASC 740, which, among other things, requires that we estimate our annual effective income tax rate for the full year and apply it to pre-tax income (loss) for each interim period, taking into account year-to-date amounts and projected results for the full year. We periodically evaluate whether we will recover a portion or all of our deferred tax assets. We record a valuation allowance against our deferred tax assets if and to the extent it is more likely than not that we will not recover our deferred tax assets. In evaluating the need for a valuation allowance, we weight all relevant positive and negative evidence, including among other factors, historical financial performance, forecasts of income over the applicable carryforward periods, and our market environment, with each piece weighted based on its reliability. As of March 31, 2023, we had insufficient objective positive evidence that we will generate sufficient future pre-tax income to overcome the negative evidence of cumulative losses. Accordingly, we continue to record a full valuation allowance against our net U.S. and U.K. deferred tax assets as of March 31, 2023.We account for the tax effects of discrete events in the interim period they occur. The provision for income taxes consists of federal, foreign, state, and local income taxes. Our effective tax rate differs from the statutory U.S. income tax rate due to the effect of state and local income taxes, differing tax rates imposed on income earned in foreign jurisdictions and in the United States, losses in foreign jurisdictions, certain nondeductible expenses, excess tax deductions, and the changes in valuation allowances against our deferred tax assets. Our effective tax rate could change significantly from quarter to quarter because of recurring and nonrecurring factors.

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The disaggregation of revenue by region was as follows (in thousands): Three Months Ended March 31, 2023 2022 Revenue by region: United States $ 143,665 $ 110,033 International 55,422 47,908 Total $ 199,087 $ 157,941
Deferred Contract Costs	A summary of the activity impacting our deferred commissions during the three months ended March 31, 2023 and 2022 is presented below (in thousands): Three Months Ended March 31, 2023 2022 Beginning balance (1) $ 96,239 $ 69,817 Additional deferred commissions 17,065 10,968 Amortization of deferred commissions (17,965) (13,028) Effects of foreign currency translation 278 (286) Ending balance $ 95,617 $ 67,471

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Summary of Cash and Cash Equivalents and Investments' Costs, Gross Unrealized Gains (Losses), and Fair Value by Major Security Type Recorded as Cash and Cash Equivalents or Short-Term or Long-Term Investments	The following tables present our cash and cash equivalents’ and investments’ costs, net unrealized gains (losses), and fair value by major security type recorded as cash and cash equivalents or short-term or long-term investments as of March 31, 2023 and December 31, 2022 (in thousands): As of March 31, 2023 Cost Net Fair Value Cash and Short-term Long-term Cash $ 72,343 $ — $ 72,343 $ 72,343 $ — $ — Level 1: Money market funds 488,317 — 488,317 488,317 — — Subtotal 488,317 — 488,317 488,317 — — Level 2: Commercial paper 76,489 (36) 76,453 29,843 46,610 — Certificates of deposit 5,016 — 5,016 — 5,016 — U.S. Treasury and agency bonds 205,558 (1,566) 203,992 2,988 121,718 79,286 Corporate bonds 39,281 (334) 38,947 — 34,190 4,757 Subtotal 326,344 (1,936) 324,408 32,831 207,534 84,043 Level 3: — — — — — — Total $ 887,004 $ (1,936) $ 885,068 $ 593,491 $ 207,534 $ 84,043 As of December 31, 2022 Cost Net Fair Value Cash and Short-term Long-term Cash $ 62,880 $ — $ 62,880 $ 62,880 $ — $ — Level 1: Money market funds 20,210 — 20,210 20,210 — — Subtotal 20,210 — 20,210 20,210 — — Level 2: Commercial paper 60,197 (115) 60,082 21,064 39,018 — Certificates of deposit 6,000 (3) 5,997 — 5,997 — U.S. Treasury and agency bonds 236,559 (3,065) 233,494 597 156,090 76,807 Corporate bonds 46,171 (609) 45,562 — 35,935 9,627 Subtotal 348,927 (3,792) 345,135 21,661 237,040 86,434 Level 3: — — — — — — Total $ 432,017 $ (3,792) $ 428,225 $ 104,751 $ 237,040 $ 86,434

Balance Sheet Components (Table

Balance Sheet Components (Tables)	3 Months Ended
	Mar. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): March 31, 2023 December 31, 2022 Contract asset $ 68,518 $ 59,669 Deferred commissions 42,240 41,139 Prepaid expenses 36,520 37,783 Other 12,671 7,176 Total $ 159,949 $ 145,767
Schedule of Other Assets	Other assets consisted of the following (in thousands): March 31, 2023 December 31, 2022 Contract asset $ 63,931 $ 71,448 Deferred commissions 53,378 55,100 Other 17,602 14,258 Total $ 134,911 $ 140,806

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Change in Carrying Amount of Goodwill	The change in carrying amount of goodwill for the three months ended March 31, 2023 was as follows (in thousands): Goodwill as of December 31, 2022 $ 398,091 Effects of foreign currency translation (266) Goodwill as of March 31, 2023 $ 397,825
Schedule of Intangible Assets	Intangible assets consisted of the following (in thousands, except years): As of March 31, 2023 Remaining Weighted-Average Useful Life in Years Gross Carrying Accumulated Net Carrying Customer relationships 1.9 $ 2,436 $ (1,431) $ 1,005 Completed technology 5.5 82,023 (26,785) 55,238 Trade names 1.9 1,500 (572) 928 $ 85,959 $ (28,788) $ 57,171 As of December 31, 2022 Remaining Weighted-Average Useful Life in Years Gross Carrying Accumulated Net Carrying Customer relationships 2.1 $ 2,466 $ (1,320) $ 1,146 Completed technology 5.6 82,209 (23,506) 58,703 Trade names 2.1 1,500 (448) 1,052 $ 86,175 $ (25,274) $ 60,901
Schedule of Finite-Lived Intangible Assets Estimated Remaining Amortization Expense	The following table presents our estimates of remaining amortization expense for finite-lived intangible assets at March 31, 2023 (in thousands): Remainder of 2023 $ 8,872 2024 11,779 2025 10,181 2026 9,298 2027 8,311 Thereafter 8,730 Total amortization expense $ 57,171

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
Schedule of Debt	Our debt consisted of the following, which comprises the current portion of certain convertible notes, our long-term convertible notes, and our long-term senior unsecured notes, each as further described below (in thousands): As of March 31, 2023 As of December 31, 2022 2023 Notes 2024 Notes 2026 Notes 2028 Notes 2023 Notes 2024 Notes 2026 Notes Liability: Principal $ 82,748 $ 400,000 $ 400,000 $ 450,000 $ 84,748 $ 400,000 $ 400,000 Less: debt discount and issuance costs, net of amortization (69) (2,292) (4,102) (9,354) (177) (2,700) (4,379) Net carrying amount $ 82,679 $ 397,708 $ 395,898 $ 440,646 $ 84,571 $ 397,300 $ 395,621
Summary of Convertible Debt	The following table presents details of our convertible senior notes, which are further discussed below (original principal in thousands): Month Issued Maturity Date Original Principal (including over-allotment) Coupon Interest Rate Effective Interest Rate Conversion Rate Initial Conversion Price 2023 Notes May and June 2018 June 1, 2023 $ 230,000 0.5 % 1.00 % $ 22.5572 $ 44.33 2024 Notes August 2019 August 1, 2024 $ 400,000 0.5 % 0.93 % $ 5.2809 $ 189.36 2026 Notes August 2019 August 1, 2026 $ 400,000 1.0 % 1.32 % $ 5.2809 $ 189.36
Summary of Interest Expense	The following table sets forth interest expense recognized related to the Notes (in thousands): Three Months Ended March 31, 2023 2022 Contractual interest expense $ 4,337 $ 1,606 Amortization of debt issuance costs and discount 892 780 Total $ 5,229 $ 2,386
Contractual Obligation, Fiscal Year Maturity	The following table sets forth future contractual obligations of contractual interest and principal related to the Notes (in thousands): Payments Due by Period Remainder of 2023 $ 106,627 2024 445,375 2025 43,375 2026 443,375 2027 39,375 2028 469,688 Total principal and related contractual interest $ 1,547,815

Equity Awards (Tables)

Equity Awards (Tables)	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	Stock option activity, excluding activity related to the employee stock purchase plan, during the three months ended March 31, 2023 consisted of the following (in thousands, except weighted-average information): Options Weighted- Options outstanding at December 31, 2022 1,106 $ 41.43 Granted — — Exercised (11) 13.07 Canceled/forfeited — — Options outstanding at March 31, 2023 1,095 $ 41.71
Schedule of RSU Activity	Restricted stock unit, or RSU, and performance-based RSU, or PRSU, activity during the three months ended March 31, 2023 consisted of the following (in thousands, except weighted-average information): Awards Outstanding (1) Weighted- Average Grant Date Fair Value (1) RSUs outstanding at December 31, 2022 9,928 $ 55.70 Granted 2,710 64.60 Vested (1,186) 68.03 Canceled/forfeited (419) 64.09 RSUs outstanding at March 31, 2023 11,033 $ 56.24 (1) Includes restricted stock units with market, performance, and/or service conditions.
Schedule of Stock-based Compensation Expense	We classified stock-based compensation expense in the accompanying condensed consolidated statements of operations and comprehensive loss as follows (in thousands): Three Months Ended March 31, 2023 2022 Cost of revenue $ 3,315 $ 3,404 Research and development 14,056 11,174 Sales and marketing 22,623 15,220 General and administrative 17,479 15,364 Total $ 57,473 $ 45,162

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of Provision for Income Taxes and Effective Tax Rates	The following table presents details of the provision for income taxes and our effective tax rates (in thousands, except percentages): Three Months Ended March 31, 2023 2022 Provision for income taxes $ 2,575 $ 1,488 Effective tax rate (3.0) % (1.4) %

Basic and Diluted Net Loss Pe_2

Basic and Diluted Net Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule of Net Income Per Share	The following table presents the computation of net loss per share (in thousands, except per share amounts): Three Months Ended March 31, 2023 2022 Numerator: Net loss attributable to common stockholders $ (89,035) $ (105,567) Denominator: Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted 69,874 67,826 Net loss per share attributable to common stockholders, basic and diluted $ (1.27) $ (1.56)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following weighted-average equivalent shares of common stock were excluded from the diluted net loss per share calculation because their inclusion would have been anti-dilutive (in thousands): Three Months Ended March 31, 2023 2022 Stock awards 8,284 7,018 Convertible senior notes 5,618 6,136 Total shares excluded from net loss per share 13,902 13,154

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 199,087	$ 157,941
United States
Disaggregation of Revenue [Line Items]
Total revenue	143,665	110,033
International
Disaggregation of Revenue [Line Items]
Total revenue	$ 55,422	$ 47,908

Revenue - Contract Assets and C

Revenue - Contract Assets and Contract Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Contract With Customer, Contract Assets and Contract Liabilities [Line Items]
Contract with customer, liability, current	$ 212,458		$ 276,160
Revenue recognized related to amounts that were included in deferred revenue	127,000	$ 83,200
Contract with Customer, Liability, Current
Contract With Customer, Contract Assets and Contract Liabilities [Line Items]
Contract with customer, liability, current	212,500		276,200
Other Noncurrent Liabilities
Contract With Customer, Contract Assets and Contract Liabilities [Line Items]
Deferred revenue	$ 6,200		$ 4,000

Revenue - Assets Recognized fro

Revenue - Assets Recognized from Costs to Obtain Contracts with Customers (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Jan. 01, 2023	Jan. 01, 2022
Change in Capitalized Contract Costs [Roll Forward]
Beginning balance	$ 96,239,000	$ 69,817,000
Additional deferred commissions	17,065,000	10,968,000
Amortization of deferred commissions	(17,965,000)	(13,028,000)
Effects of foreign currency translation	278,000	(286,000)
Ending balance	95,617,000	67,471,000
Capitalized contract cost, net	95,617,000	67,471,000
Capitalized contract cost, net, current	42,200,000	30,800,000
Impairments of assets related to deferred contract costs	0	0
Capitalized contract cost	$ 0	$ 0
Class A common stock
Change in Capitalized Contract Costs [Roll Forward]
Capitalized contract cost, net			$ 1,600,000	$ 6,300,000

Revenue - Remaining Performance

Revenue - Remaining Performance Obligation (Details) $ in Millions	Mar. 31, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, amount	$ 508.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, amount	$ 474.2
Remaining performance obligation, period	24 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, period

Business Combinations - Additio

Business Combinations - Additional Information (Detail) - USD ($) $ in Thousands		2 Months Ended	3 Months Ended
	Feb. 07, 2022	Mar. 31, 2022	Mar. 31, 2022	Mar. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Goodwill				$ 397,825	$ 398,091
Trifacta Inc.
Business Acquisition [Line Items]
Business combination acquired percentage	100%
Cash paid to acquire business	$ 398,400
Goodwill	341,400
Trifacta Inc. | General and administrative
Business Acquisition [Line Items]
Acquisition related costs		$ 11,300	$ 7,800
Trifacta Inc. | Completed technology
Business Acquisition [Line Items]
Business combination, recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles	$ 48,500
Trifacta Inc. | Completed technology | Level 3 | Measurement Input, Discount Rate
Business Acquisition [Line Items]
Business combination, measurement input, discount rate	0.165

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Cash and Cash Equivalents and Investments' Costs, Gross Unrealized Gains (Losses), and Fair Value by Major Security Type Recorded as Cash and Cash Equivalents or Short-Term or Long-Term Investments (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	$ 593,491	$ 104,751
Investments, fair value	238,400
Short-term Investments	207,534	237,040
Long-term Investments	84,043	90,184
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	593,491	104,751
Net Unrealized Gains (Losses)	(1,936)	(3,792)
Cash and cash equivalents and investment, cost	887,004	432,017
Cash and cash equivalents and investments, fair value	885,068	428,225
Short-term Investments	207,534	237,040
Long-term Investments	84,043	86,434
Fair Value, Measurements, Recurring | Cash
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	72,343	62,880
Cash and cash equivalents, fair value	72,343	62,880
Fair Value, Measurements, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	488,317	20,210
Cash and cash equivalents, fair value	488,317	20,210
Fair Value, Measurements, Recurring | Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	488,317	20,210
Cash and cash equivalents, fair value	488,317	20,210
Fair Value, Measurements, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	32,831	21,661
Investments, cost	326,344	348,927
Net Unrealized Gains (Losses)	(1,936)	(3,792)
Investments, fair value	324,408	345,135
Short-term Investments	207,534	237,040
Long-term Investments	84,043	86,434
Fair Value, Measurements, Recurring | Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	29,843	21,064
Investments, cost	76,489	60,197
Net Unrealized Gains (Losses)	(36)	(115)
Investments, fair value	76,453	60,082
Short-term Investments	46,610	39,018
Long-term Investments	0	0
Fair Value, Measurements, Recurring | Level 2 | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	0
Investments, cost	5,016	6,000
Net Unrealized Gains (Losses)	0	(3)
Investments, fair value	5,016	5,997
Short-term Investments	5,016	5,997
Long-term Investments	0	0
Fair Value, Measurements, Recurring | Level 2 | U.S. Treasury and agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	2,988	597
Investments, cost	205,558	236,559
Net Unrealized Gains (Losses)	(1,566)	(3,065)
Investments, fair value	203,992	233,494
Short-term Investments	121,718	156,090
Long-term Investments	79,286	76,807
Fair Value, Measurements, Recurring | Level 2 | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	0
Investments, cost	39,281	46,171
Net Unrealized Gains (Losses)	(334)	(609)
Investments, fair value	38,947	45,562
Short-term Investments	34,190	35,935
Long-term Investments	4,757	9,627
Fair Value, Measurements, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and Cash Equivalents	0	0
Investments, cost	0	0
Net Unrealized Gains (Losses)	0	0
Investments, fair value	0	0
Short-term Investments	0	0
Long-term Investments	$ 0	$ 0

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Fair Value Disclosures [Line Items]
Gross unrealized losses	$ 2,100,000
Investments, fair value	238,400,000
Fair value of notes	1,281,300,000	$ 805,800,000
Other investments	6,400,000	$ 3,800,000
Other investments, impairment	$ 0
Minimum
Fair Value Disclosures [Line Items]
Long-term investments maturity period	1 year
Maximum
Fair Value Disclosures [Line Items]
Long-term investments maturity period	2 years

Balance Sheet Components - Prep

Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Contract asset	$ 68,518	$ 59,669
Deferred commissions	42,240	41,139
Prepaid expenses	36,520	37,783
Other	12,671	7,176
Prepaid expenses and other current assets	$ 159,949	$ 145,767

Balance Sheet Components - Othe

Balance Sheet Components - Other Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Contract asset	$ 63,931	$ 71,448
Deferred commissions	53,378	55,100
Other	17,602	14,258
Total	$ 134,911	$ 140,806

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Change in Carrying Amount of Goodwill (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Goodwill [Roll Forward]
Goodwill as of December 31, 2022	$ 398,091
Effects of foreign currency translation	(266)
Goodwill as of March 31, 2023	$ 397,825

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value	$ 85,959	$ 86,175
Accumulated Amortization	(28,788)	(25,274)
Net Carrying Value	$ 57,171	$ 60,901
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Remaining Weighted-Average Useful Life in Years	1 year 10 months 24 days	2 years 1 month 6 days
Gross Carrying Value	$ 2,436	$ 2,466
Accumulated Amortization	(1,431)	(1,320)
Net Carrying Value	$ 1,005	$ 1,146
Completed technology
Finite-Lived Intangible Assets [Line Items]
Remaining Weighted-Average Useful Life in Years	5 years 6 months	5 years 7 months 6 days
Gross Carrying Value	$ 82,023	$ 82,209
Accumulated Amortization	(26,785)	(23,506)
Net Carrying Value	$ 55,238	$ 58,703
Trade names
Finite-Lived Intangible Assets [Line Items]
Remaining Weighted-Average Useful Life in Years	1 year 10 months 24 days	2 years 1 month 6 days
Gross Carrying Value	$ 1,500	$ 1,500
Accumulated Amortization	(572)	(448)
Net Carrying Value	$ 928	$ 1,052

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets Estimated Remaining Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2023	$ 8,872
2024	11,779
2025	10,181
2026	9,298
2027	8,311
Thereafter	8,730
Net Carrying Value	$ 57,171	$ 60,901

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Aug. 31, 2019	Jun. 30, 2018
Debt Instrument [Line Items]
Net carrying amount	$ 1,234,252	$ 792,921
Convertible senior note due 2023, 0.5% | Convertible senior notes
Debt Instrument [Line Items]
Principal	82,748	84,748		$ 230,000
Less: debt discount and issuance costs, net of amortization	(69)	(177)
Net carrying amount	82,679	84,571
Convertible senior note due 2024, 0.50% | Convertible senior notes
Debt Instrument [Line Items]
Principal	400,000	400,000	$ 400,000
Less: debt discount and issuance costs, net of amortization	(2,292)	(2,700)
Net carrying amount	397,708	397,300
Convertible senior note due 2026, 1.0% | Convertible senior notes
Debt Instrument [Line Items]
Principal	400,000	400,000	$ 400,000
Less: debt discount and issuance costs, net of amortization	(4,102)	(4,379)
Net carrying amount	395,898	$ 395,621
Senior Notes Due 2028 | Senior Notes
Debt Instrument [Line Items]
Principal	450,000
Less: debt discount and issuance costs, net of amortization	(9,354)
Net carrying amount	$ 440,646

Debt - Additional Information (

Debt - Additional Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($) d shares	Dec. 31, 2022 USD ($)	Aug. 31, 2019 $ / option	Jun. 30, 2018 USD ($) $ / option
Debt Instrument [Line Items]
Redemption price, percentage	100%
Conversion of 2023 Notes, net of tax	$ (3)
Class A common stock
Debt Instrument [Line Items]
Shares retired (in shares) | shares	9,394
Conversion of 2023 Notes, net of tax	$ 2,000
Conversion on 2023 Notes, net of tax (in shares) | shares	8,598
Price risk derivative
Debt Instrument [Line Items]
Capped calls, initial strike price (in dollars per share) | $ / option			189.36	44.33
Capped calls, cap price (in dollars per share) | $ / option			315.60	62.22
Convertible senior notes | Convertible senior notes due 2023, 2024, 2026 | Debt instrument, conversion, option one
Debt Instrument [Line Items]
Convertible debt, threshold trading days | d	20
Convertible debt, threshold consecutive trading days | d	30
Convertible debt, threshold percentage of stock price trigger	130%
Convertible senior notes | Convertible senior notes due 2023, 2024, 2026 | Debt instrument, conversion, option two
Debt Instrument [Line Items]
Convertible debt, threshold trading days | d	5
Convertible debt, threshold consecutive trading days | d	5
Convertible debt, threshold percentage of stock price trigger	98%
Convertible senior notes | Convertible senior note due 2023, 0.5%
Debt Instrument [Line Items]
Principal	$ 82,748	$ 84,748		$ 230,000
Coupon Interest Rate				0.50%
Effective Interest Rate				1%
If-converted value in excess of principal	27,100
Convertible debt	2,000
Senior Notes | Senior Notes Due 2028
Debt Instrument [Line Items]
Principal	$ 450,000
Coupon Interest Rate	8.75%
Effective Interest Rate	9.27%
Senior Notes | Senior Notes Due 2028 | Debt instrument, conversion, option one
Debt Instrument [Line Items]
Redemption price, percentage	100%
Senior Notes | Senior Notes Due 2028 | Debt instrument, conversion, option two
Debt Instrument [Line Items]
Redemption price, percentage	108.75%
Debt instrument, redemption price, percentage of principal amount redeemed	40%

Debt - Summary of Debt (Details

Debt - Summary of Debt (Details) $ / shares in Units, $ in Thousands	1 Months Ended	2 Months Ended
	Aug. 31, 2019 USD ($) $ / shares	Jun. 30, 2018 USD ($) $ / shares	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Convertible senior notes | Convertible senior note due 2023, 0.5%
Debt Instrument [Line Items]
Original Principal (including over-allotment)		$ 230,000	$ 82,748	$ 84,748
Coupon Interest Rate		0.50%
Effective Interest Rate		1%
Conversion Rate		0.0225572
Initial Conversion Price (in usd per share) | $ / shares		$ 44.33
Convertible senior notes | Convertible senior note due 2024, 0.50%
Debt Instrument [Line Items]
Original Principal (including over-allotment)	$ 400,000		400,000	400,000
Coupon Interest Rate	0.50%
Effective Interest Rate	0.93%
Conversion Rate	0.0052809
Initial Conversion Price (in usd per share) | $ / shares	$ 189.36
Convertible senior notes | Convertible senior note due 2026, 1.0%
Debt Instrument [Line Items]
Original Principal (including over-allotment)	$ 400,000		400,000	$ 400,000
Coupon Interest Rate	1%
Effective Interest Rate	1.32%
Conversion Rate	0.0052809
Initial Conversion Price (in usd per share) | $ / shares	$ 189.36
Senior Notes | Senior Notes Due 2028
Debt Instrument [Line Items]
Original Principal (including over-allotment)			$ 450,000
Coupon Interest Rate			8.75%
Effective Interest Rate			9.27%

Debt - Summary of Interest Expe

Debt - Summary of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Debt Disclosure [Abstract]
Contractual interest expense	$ 4,337	$ 1,606
Amortization of debt discount and issuance costs	892	780
Total	$ 5,229	$ 2,386

Debt - Schedule of Contractual

Debt - Schedule of Contractual Obligations and Contractual Interest (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Debt Disclosure [Abstract]
Remainder of 2023	$ 106,627
2024	445,375
2025	43,375
2026	443,375
2027	39,375
2028	469,688
Total principal and related contractual interest	$ 1,547,815

Equity Awards - Schedule of Sto

Equity Awards - Schedule of Stock Option Activity (Details) shares in Thousands	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Options Outstanding
Options outstanding, beginning balance (in shares) | shares	1,106
Granted (in shares) | shares	0
Exercised (in shares) | shares	(11)
Canceled/forfeited (in shares) | shares	0
Options outstanding, ending balance (in shares) | shares	1,095
Weighted- Average Exercise Price
Weighted-average exercise price, beginning balance (in dollars per share) | $ / shares	$ 41.43
Weighted-average exercise price, granted (in dollars per share) | $ / shares	0
Weighted-average exercise price, exercised (in dollars per share) | $ / shares	13.07
Weighted-average exercise price, canceled/forfeited (in dollars per share) | $ / shares	0
Weighted-average exercise price, ending balance (in dollars per share) | $ / shares	$ 41.71

Equity Awards - Additional Info

Equity Awards - Additional Information (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to unvested stock options	$ 2.4
Weighted-average period, expected to be recognized	1 year 1 month 6 days
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average period, expected to be recognized	2 years 2 months 12 days
Aggregate grant date fair value	$ 13.9
Unrecognized compensation expense, related to unvested RSUs	$ 518.8

Equity Awards - Schedule of RSU

Equity Awards - Schedule of RSU Activity (Details) - Restricted stock units shares in Thousands	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Awards Outstanding
Beginning balance (in shares) | shares	9,928
Granted (in shares) | shares	2,710
Vested (in shares) | shares	(1,186)
Canceled/forfeited (in shares) | shares	(419)
Ending balance (in shares) | shares	11,033
Weighted- Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 55.70
Granted (in dollars per share) | $ / shares	64.60
Vested (in dollars per share) | $ / shares	68.03
Canceled/forfeited (in dollars per share) | $ / shares	64.09
Ending balance (in dollars per share) | $ / shares	$ 56.24

Equity Awards - Schedule of S_2

Equity Awards - Schedule of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	$ 57,473	$ 45,162
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	3,315	3,404
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	14,056	11,174
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	22,623	15,220
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	$ 17,479	$ 15,364

Contingencies (Details)

Contingencies (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Indemnification
Commitments And Contingencies [Line Items]
Loss contingency accrual	$ 0	$ 0

Income Taxes - Schedule of Prov

Income Taxes - Schedule of Provision for Income Taxes and Effective Tax Rates (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 2,575	$ 1,488
Effective tax rate	(3.00%)	(1.40%)

Basic and Diluted Net Loss Pe_3

Basic and Diluted Net Loss Per Share - Schedule of Computation of Net Loss per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Numerator:
Net loss attributable to common stockholders	$ (89,035)	$ (105,567)
Denominator:
Weighted-average shares used to compute net income (loss) per share attributable to common stockholders, basic (in shares)	69,874	67,826
Weighted-average shares used to compute net income (loss) per share attributable to common stockholders, diluted (in shares)	69,874	67,826
Net income (loss) per share attributable to common stockholders, basic (in dollars per share)	$ (1.27)	$ (1.56)
Net income (loss) per share attributable to common stockholders, diluted (in dollars per share)	$ (1.27)	$ (1.56)

Basic and Diluted Net Loss Pe_4

Basic and Diluted Net Loss Per Share - Weighted-average Equivalent Shares Excluded From Diluted Net Loss per Share Calculation (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Securities excluded from calculation of earnings per share (in shares)	13,902	13,154
Stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Securities excluded from calculation of earnings per share (in shares)	8,284	7,018
Convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Securities excluded from calculation of earnings per share (in shares)	5,618	6,136

Subsequent Event (Details)

Subsequent Event (Details) - Subsequent event $ in Millions	Apr. 27, 2023 USD ($)
Minimum
Subsequent Event [Line Items]
Restructuring and related cost, expected cost	$ 11
Maximum
Subsequent Event [Line Items]
Restructuring and related cost, expected cost	$ 13

Uncategorized Items - ayx-20230

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2020-06 [Member]